Garland J. Scott
Reporting owner on Forms 3, 4 and 5, CIK 1533228.
Garland J. Scott reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Enliven Therapeutics, Inc. CIK 1672619 | director | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. Common Stock | 2026-10-01 | M exercised | +13,000 | $15.47 | 13,000 | Form 4 |
| Enliven Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -13,000 | $46.6707 | 0 | Form 4 |
| Enliven Therapeutics, Inc. Stock Option (right to buy), derivative | 2026-10-01 | M exercised | -13,000 | $0 | 46,372 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001533228-26-000009 | Enliven Therapeutics, Inc. | 2026-10-05 |